A Prospective 1-Year Follow-up of Glycemic Status and C-Peptide Levels of COVID-19 Survivors with Dysglycemia in Acute COVID-19 Infection.

David Tak Wai LuiChi Ho LeeYing WongCarol Ho Yi FongKimberly Hang TsoiYu Cho WooKathryn Choon Beng Tan

Published in: Diabetes & metabolism journal (2024)

Subjects who had dysglycemia in acute COVID-19 were characterized by insulin resistance. Over 1 year, a quarter had progression in glycemic status, especially those with more severe COVID-19. Importantly, there was no significant deterioration in insulin secretory capacity.

Keyphrases

coronavirus disease
sars cov
type diabetes
liver failure
insulin resistance
glycemic control
respiratory failure
drug induced
respiratory syndrome coronavirus
metabolic syndrome
young adults
adipose tissue
early onset
intensive care unit
acute respiratory distress syndrome